Literature DB >> 10910970

Influenza virus infection of desialylated cells.

S J Stray1, R D Cummings, G M Air.   

Abstract

Sialic acid has long been considered to be the sole receptor for influenza virus. The viral hemagglutinin (HA) is known to bind cell surface sialic acid, and sialic acids on viral glyco-proteins are cleaved by the viral neuraminidase (NA) to promote efficient release of progeny virus particles. However, NWS-Mvi, a mutant virus completely lacking NA, grows well in MDCK cells continuously treated with exogenous neuraminidase (sialidase). Exogenous sialidase quantitatively releases all sialic acids from purified glycoproteins and glycolipids of MDCK cells and efficiently removes surface sialic acid from intact cells. Binding of NWS-Mvi and parent influenza viruses to MDCK cells is indistinguishable, and is only partially reduced by sialidase treatment of the cells. Both mutant and wild-type viruses enter enzymatically desialylated cells and initiate transcription. The ability of influenza A reassortant viruses to infect desialylated cells is shared by recent H3N2 clinical isolates, suggesting that this may be a general property of influenza A viruses. We propose that influenza virus infection can result from sialic acid-independent receptors, either directly or in a multistage process. When sialic acid is present, it may act to enhance virus binding to the cell surface to increase interaction with secondary receptors to mediate entry. Understanding virus entry will be critical to further efforts in infection control and prevention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910970     DOI: 10.1093/glycob/10.7.649

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  55 in total

1.  Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

Authors:  Upma Gulati; Chi-Ching Hwang; Lalitha Venkatramani; Shelly Gulati; Stephen J Stray; Janis T Lee; W Graeme Laver; Alexey Bochkarev; Adam Zlotnick; Gillian M Air
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Search for additional influenza virus to cell interactions.

Authors:  E M Rapoport; L V Mochalova; H-J Gabius; J Romanova; N V Bovin
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

3.  Comment on: concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza.

Authors:  John M Nicholls; Laura M Aschenbrenner; James C Paulson; Erin R Campbell; Michael P Malakhov; David F Wurtman; Mang Yu; Fang Fang
Journal:  J Antimicrob Chemother       Date:  2008-04-22       Impact factor: 5.790

4.  CHoMP: a chemoenzymatic histology method using clickable probes.

Authors:  Sara H Rouhanifard; Aimé López-Aguilar; Peng Wu
Journal:  Chembiochem       Date:  2014-11-17       Impact factor: 3.164

5.  Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems.

Authors:  Felix W Santiago; Kris Lambert Emo; Theresa Fitzgerald; John J Treanor; David J Topham
Journal:  Vaccine       Date:  2012-05-15       Impact factor: 3.641

6.  Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.

Authors:  Michael P Malakhov; Laura M Aschenbrenner; Donald F Smee; Miles K Wandersee; Robert W Sidwell; Larisa V Gubareva; Vasiliy P Mishin; Frederick G Hayden; Do Hyong Kim; Alice Ing; Erin R Campbell; Mang Yu; Fang Fang
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Analysis of influenza virus hemagglutinin receptor binding mutants with limited receptor recognition properties and conditional replication characteristics.

Authors:  Konrad C Bradley; Summer E Galloway; Yi Lasanajak; Xuezheng Song; Jamie Heimburg-Molinaro; Hai Yu; Xi Chen; Ganesh R Talekar; David F Smith; Richard D Cummings; David A Steinhauer
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

Review 8.  Investigating virus-glycan interactions using glycan microarrays.

Authors:  David F Smith; Richard D Cummings
Journal:  Curr Opin Virol       Date:  2014-07-01       Impact factor: 7.090

9.  Context-specific target definition in influenza a virus hemagglutinin-glycan receptor interactions.

Authors:  Zachary Shriver; Rahul Raman; Karthik Viswanathan; Ram Sasisekharan
Journal:  Chem Biol       Date:  2009-08-28

10.  Human Alveolar Macrophages May Not Be Susceptible to Direct Infection by a Human Influenza Virus.

Authors:  David B Ettensohn; Mark W Frampton; Joan E Nichols; Norbert J Roberts
Journal:  J Infect Dis       Date:  2016-09-06       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.